Sunday, February 23, 2025

Long-Term Immune Responses Linked to Stem-Like T Cells

Must read


Register for free to listen to this article

Thank you. Listen to this article using the player above.


Want to listen to this article for FREE?


Complete the form below to unlock access to ALL audio articles.

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders – T cells – lose their ability to function effectively. Research, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and the Peter MacCallum Cancer Centre (Peter Mac), have identified a rare type of immune cells, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses.

Published in Science Immunology, the study revealed that the endurance of these stem-like T cells is fuelled by a protein called ID3, expressed by a gene of the same name. These ID3+ T cells have a unique ability to self-renew and resist exhaustion, giving them the power to sustain immune responses far longer than other T cells that don’t express ID3.

The University of Melbourne’s Catarina Gago da Graça, PhD Candidate at the Doherty Institute, said the research highlights how ID3+ T cells hold the key to overcoming one of the biggest challenges in treating chronic diseases—immune exhaustion.

“ID3+ T cells have the remarkable ability to resist burnout and maintain a powerful immune response over time, making them particularly effective in the face of chronic infections or cancer,” said and co-first author Gago da Graça.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

The research also found that certain signals in the body could increase the number of ID3+ T cells, paving the way for improved treatments like CAR T cell therapy. While CAR T therapy has been transformative in treating certain cancers, its effectiveness can wane over time due to T cell exhaustion.

Professor Ricky Johnstone, Executive Director Cancer Research at Peter Mac and co-lead author of the study, said enhancing ID3 activity could strengthen the endurance of these cells, making therapies more effective and long-lasting.

“We discovered that ID3+ T cell formation could be promoted by specific inflammatory cues, potentially offering new strategies to boost the number of immune cells that excel at fighting cancer in patients,” said Professor Johnstone.

“This could lead to better treatments for cancer patients and improve clinical immunotherapy outcomes.”

The University of Melbourne’s Dr Daniel Utzschneider, Laboratory Head at the Doherty Institute, said the findings could lead to advancements in immunotherapy treatments and the development of vaccines that provide long-lasting protection.

“Exhausted immune cells remain one of the biggest challenges in treating chronic diseases,” said Dr Utzschneider.

“This research provides a roadmap for how we might reinvigorate the immune system to improve health outcomes for people living with cancer or chronic infections like HIV or hepatitis B and C, thanks to these stem-like T cells, the immune system’s secret power.”

Reference: Gago da Graça C, Sheikh AA, Newman DM, et al. Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression. Sci Immunol. 2025;10(103):eadn1945. doi: 10.1126/sciimmunol.adn1945

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.

Latest article